JPRN-jRCT2080220660未知3 期
Randomized trial of oxaliplatin plus S-1 (SOX) versus S-1 alone in patients with gemcitabine-refractory pancreatic cancer
试验速览
- 阶段
- 3 期
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Histologically or cytologically proven pancreatic adenocarcinoma or adenosquamous carcinoma
- •Gemcitabine refractory
- •Taking orally
- •ECOG performance status (PS) :0-1
- •Measurable metastatic disease based on RECIST criteria
排除标准
- •Prior treatment with platinum- or fluoropyrimidine -agent
- •Prior treatment with radiotherapy
研究者
相似试验
未知
3 期
A Randomized Phase III Trial of SOX/Bevacizumab versus FOLFOX/Bevacizmab in Treating Patients with Metastatic Colorectal Cancer (SOFT).JPRN-jRCT1080220674Taiho Pharmaceutical Co., Ltd.500
未知
3 期
Randomized phase III study of S-1 plus oxaliplatin compared with S-1 plus cisplatin as first-line therapy for advanced or recurrent gastric cancerAdvanced or recurrent gastric cancerJPRN-jRCT2080220988Yakult Honsha Co.,Ltd.
已完成
3 期
Phase III Adjuvant Chemotherapy of S-1 plus Oxaliplatin for Colorecrtal Cancer (ACTS-CC 02)JPRN-jRCT1080221040Taiho Pharmaceutical Co., Ltd.1,200
未知
Unknown
A phase 1/2 trial of Oxaliplatin(L-OHP) + S-1 in patients with previously untreated advanced colorectal cancerColorectal cancerJPRN-jRCT2080220116Yakult Honsha Co.,Ltd.
已完成
1 期
Phase I Trial of S-1 and Weekly Oxaliplatin in Combination with Radiotherapy for Neoadjuvant Therapy of Locally Advanced Rectum CancerRectal cancer of Stage II or III with T4 or lateral lymph node metastasis at the pre-operative diagnosisJPRN-UMIN000002845ational cancer center hosital12